Suppr超能文献

2020年波兰的结核病情况

Tuberculosis in Poland in 2020.

作者信息

Korzeniewska-Koseła Maria, Wesołowski Stefan

机构信息

Department of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute.

National Tuberculosis and Lung Diseases Research Institute, the Institute Director.

出版信息

Przegl Epidemiol. 2022;76(4):528-546. doi: 10.32394/pe.76.48.

Abstract

AIM OF THE STUDY

To evaluate the main features of epidemiology of tuberculosis (TB) in 2020 in Poland and to compare with the situation in the European Union and European Economic Area (EU/EEA) countries.

MATERIAL AND METHODS

Analysis of case-based data on TB patients from National TB Register, data on anti-TB drug susceptibility in cases notified in 2020, data from Statistics Poland on deaths from tuberculosis in 2019, data from National Institute of Public Health NIH - National Research Institute (NIPH NIH - NRI) on HIV-positive subjects for whom TB was an AIDS-defining disease, data from the report "European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2022 - 2020 data. Copenhagen: WHO Regional Office for Europe and Stockholm: European Centre for Disease Prevention and Control; 2022."

RESULTS

In 2020, 3,388 TB cases were reported in Poland. The incidence rate was 8.8 cases per 100,000 with large variability between voivodeships from 5.5 to 13.3 per 100,000. A decrease in the incidence was found in 15 voivodeships, the most significant in Śląskie voivodship (63.9%). The number of all pulmonary tuberculosis cases was 3,237 i.e. 8.4 per 100,000. Pulmonary cases represented 95.5% of all TB cases. In 2020, 151 extrapulmonary TB cases were notified (4.5% of all TB cases). Pulmonary tuberculosis was bacteriologically confirmed in 2,573 cases (79.5% of all pulmonary TB cases, the incidence rate 6.7 per 100,000). The number of smear-positive pulmonary TB cases was 1,771 i.e. 4.6 per 100,000 (54.7% of all pulmonary TB cases). In 2020, there were 38 cases (15 of foreign origin) with multidrug resistant TB (MDR-TB) representing 1.6% of cases with known drug sensitivity. The incidence rates of tuberculosis were growing along with increasing age from 0.7 per 100,000 among children (0-14 years) to 15.0 per 100,000 among subjects in the age group 45-64 years, the incidence rate in the age group ≥65 years was 12.1 per 100,000. There were 39 cases in children up to 14 years of age (1.2% of the total) and 49 cases in adolescents between 15 and 19 years of age - rates 0.7 and 2.7 per 100,000 respectively. In 2020, there were 2,506 cases of tuberculosis in men and 882 in women. The TB incidence in men - 13.5 per 100,000 was 3.0 times higher than among women - 4.5. The biggest difference in the TB incidence between the two sex groups occurred in persons aged 50-54 years - 26.8 vs. 4.1 and in age group 55 to 59 years - 28.7 vs. 4.8. In 2020, there were 116 patients of foreign origin among all cases of tuberculosis in Poland (3.4%). In 2019, TB was the cause of death for 456 people (mortality rate - 1.2 per 100,000).

CONCLUSIONS

TB incidence in Poland in 2020 was 36.7% lower than in 2019. Such significant declines in the incidence have not been observed in the last two decades. As in previous years, there were differences in incidence rates between voivodeships with an unexpectedly sharp decrease in incidence in Silesia (Śląskie voivodeship). The percentage of tuberculosis cases with bacteriological confirmation exceeded 78%, more than in EU/EEA countries (67.3%). The percentage of MDR-TB cases was still lower than the average in EU/EEA countries (1.6% vs. 3.8%). The highest incidence rates were found in Poland in the older age groups (EU/EEAaged 25 to 44). The percentage of children up to 14 years of age among the total number of TB patients was 1.2%, less than the average in EU/EEA countries (3.8%). The incidence of tuberculosis in men was three times higher than in women in Poland, and six times higher in patients aged 50 to 59. The impact of migration on the TB pattern in Poland has not yet become significant in 2020. The percentage of foreigners among TB patients was 3.4% (33% in EU/EEA countries).

摘要

研究目的

评估2020年波兰结核病(TB)的主要流行病学特征,并与欧盟和欧洲经济区(EU/EEA)国家的情况进行比较。

材料与方法

分析来自国家结核病登记册的结核病患者个案数据、2020年报告病例的抗结核药物敏感性数据、波兰国家统计局关于2019年结核病死亡数据、国家公共卫生研究所-国家研究机构(NIPH NIH - NRI)关于结核病为艾滋病界定疾病的HIV阳性受试者的数据、报告《欧洲疾病预防控制中心,世界卫生组织欧洲区域办事处。2022年欧洲结核病监测与监测 - 2020年数据。哥本哈根:世界卫生组织欧洲区域办事处和斯德哥尔摩:欧洲疾病预防控制中心;2022年》中的数据。

结果

2020年,波兰报告了3388例结核病病例。发病率为每10万人8.8例,各省份之间差异很大,从每10万人5.5例到13.3例不等。15个省份的发病率有所下降,其中西里西亚省(Śląskie voivodship)下降最为显著(63.9%)。所有肺结核病例数为3237例,即每10万人8.4例。肺结核病例占所有结核病病例的95.5%。2020年,报告了151例肺外结核病病例(占所有结核病病例的4.5%)。2573例肺结核病例经细菌学确诊(占所有肺结核病例的79.5%,发病率为每10万人6.7例)。涂片阳性肺结核病例数为1771例,即每10万人4.6例(占所有肺结核病例的54.7%)。2020年,有38例(15例为外国来源)耐多药结核病(MDR-TB)病例,占已知药敏病例的1.6%。结核病发病率随着年龄增长而上升,从儿童(0 - 14岁)的每10万人0.7例增至45 - 64岁年龄组的每10万人15.0例,≥65岁年龄组的发病率为每10万人12.1例。14岁及以下儿童有39例(占总数的1.2%),15至19岁青少年有49例,发病率分别为每10万人0.7例和2.7例。2020年,男性有2506例结核病病例,女性有882例。男性的结核病发病率为每10万人13.5例,是女性(每10万人4.5例)的3.0倍。两个性别组之间结核病发病率的最大差异出现在50 - 54岁人群中,分别为26.8例/10万人和4.1例/10万人,以及55至59岁年龄组中,分别为28.7例/10万人和4.8例/10万人。2020年,波兰所有结核病病例中有116例为外国来源(占3.4%)。2019年,结核病导致456人死亡(死亡率为每10万人1.2例)。

结论

2020年波兰的结核病发病率比2019年低36.7%。过去二十年未观察到如此显著的发病率下降。与往年一样,各省份之间的发病率存在差异,西里西亚省(Śląskie voivodeship)的发病率意外大幅下降。细菌学确诊的结核病病例百分比超过78%,高于欧盟/EEA国家(67.3%)。耐多药结核病病例的百分比仍低于欧盟/EEA国家的平均水平(1.6%对3.8%)。波兰年龄较大的年龄组发病率最高(欧盟/EEA为25至44岁)。14岁及以下儿童在结核病患者总数中的百分比为1.2%,低于欧盟/EEA国家的平均水平(3.8%)。波兰男性的结核病发病率是女性的三倍,50至59岁患者中则是六倍。2020年,移民对波兰结核病模式的影响尚未变得显著。结核病患者中外国人的百分比为3.4%(欧盟/EEA国家为33%)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验